Literature DB >> 17916086

Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1.

Sophie Béraud-Dufour1, Romain Gautier, Corinne Albiges-Rizo, Pierre Chardin, Eva Faurobert.   

Abstract

The small G protein Rap1 regulates diverse cellular processes such as integrin activation, cell adhesion, cell-cell junction formation and cell polarity. It is crucial to identify Rap1 effectors to better understand the signalling pathways controlling these processes. Krev interaction trapped 1 (Krit1), a protein with FERM (band four-point-one/ezrin/radixin/moesin) domain, was identified as a Rap1 partner in a yeast two-hybrid screen, but this interaction was not confirmed in subsequent studies. As the evidence suggests a role for Krit1 in Rap1-dependent pathways, we readdressed this question. In the present study, we demonstrate by biochemical assays that Krit1 interacts with Rap1A, preferentially its GTP-bound form. We show that, like other FERM proteins, Krit1 adopts two conformations: a closed conformation in which its N-terminal NPAY motif interacts with its C-terminus and an opened conformation bound to integrin cytoplasmic domain associated protein (ICAP)-1, a negative regulator of focal adhesion assembly. We show that a ternary complex can form in vitro between Krit1, Rap1 and ICAP-1 and that Rap1 binds the Krit1 FERM domain in both closed and opened conformations. Unlike ICAP-1, Rap1 does not open Krit1. Using sedimentation assays, we show that Krit1 binds in vitro to microtubules through its N- and C-termini and that Rap1 and ICAP-1 inhibit Krit1 binding to microtubules. Consistently, YFP-Krit1 localizes on cyan fluorescent protein-labelled microtubules in baby hamster kidney cells and is delocalized from microtubules upon coexpression with activated Rap1V12. Finally, we show that Krit1 binds to phosphatidylinositol 4,5-P(2)-containing liposomes and that Rap1 enhances this binding. Based on these results, we propose a model in which Krit1 would be delivered by microtubules to the plasma membrane where it would be captured by Rap1 and ICAP-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916086      PMCID: PMC2580780          DOI: 10.1111/j.1742-4658.2007.06068.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  48 in total

1.  Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.

Authors:  M A Pearson; D Reczek; A Bretscher; P A Karplus
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

2.  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.

Authors:  J Zhang; R E Clatterbuck; D Rigamonti; D D Chang; H C Dietz
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

3.  Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides.

Authors:  V Martel; C Racaud-Sultan; S Dupe; C Marie; F Paulhe; A Galmiche; M R Block; C Albiges-Rizo
Journal:  J Biol Chem       Date:  2001-03-28       Impact factor: 5.157

4.  Crystallization and preliminary crystallographic analysis of the ezrin FERM domain.

Authors:  William J Smith; Richard A Cerione
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-07-20

Review 5.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

6.  Recognizing and defining true Ras binding domains II: in silico prediction based on homology modelling and energy calculations.

Authors:  Christina Kiel; Sabine Wohlgemuth; Frederic Rousseau; Joost Schymkowitz; Jesper Ferkinghoff-Borg; Fred Wittinghofer; Luis Serrano
Journal:  J Mol Biol       Date:  2005-05-06       Impact factor: 5.469

7.  Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain.

Authors:  K Hamada; T Shimizu; T Matsui; S Tsukita; T Hakoshima
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

9.  KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis.

Authors:  Jon S Zawistowski; Ilya G Serebriiskii; Maximilian F Lee; Erica A Golemis; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

10.  KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein.

Authors:  Murat Gunel; Maxwell S H Laurans; Dana Shin; Michael L DiLuna; Jennifer Voorhees; Keith Choate; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

View more
  39 in total

1.  Phosphorylation sites in the cerebral cavernous malformations complex.

Authors:  Jaehong Kim; Nicholas E Sherman; Jay W Fox; Mark H Ginsberg
Journal:  J Cell Sci       Date:  2011-12-01       Impact factor: 5.285

Review 2.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

Review 3.  Specificity in Ras and Rap signaling.

Authors:  Judith H Raaijmakers; Johannes L Bos
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

Review 4.  Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.

Authors:  Eva Faurobert; Corinne Albiges-Rizo
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

5.  FAM222B Is Not a Likely Novel Candidate Gene for Cerebral Cavernous Malformations.

Authors:  Stefanie Spiegler; Bettina Kirchmaier; Matthias Rath; G Christoph Korenke; Fabian Tetzlaff; Maartje van de Vorst; Kornelia Neveling; Amparo Acker-Palmer; Andreas W Kuss; Christian Gilissen; Andreas Fischer; Stefan Schulte-Merker; Ute Felbor
Journal:  Mol Syndromol       Date:  2016-06-18

6.  Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences β1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus.

Authors:  Kyle M Draheim; Clotilde Huet-Calderwood; Bertrand Simon; David A Calderwood
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

Review 7.  Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.

Authors:  Oriana S Fisher; Titus J Boggon
Journal:  Cell Mol Life Sci       Date:  2013-11-29       Impact factor: 9.261

8.  Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation.

Authors:  Weizhi Liu; Kyle M Draheim; Rong Zhang; David A Calderwood; Titus J Boggon
Journal:  Mol Cell       Date:  2013-01-11       Impact factor: 17.970

9.  Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke.

Authors:  Aniket V Gore; Maria Grazia Lampugnani; Louis Dye; Elisabetta Dejana; Brant M Weinstein
Journal:  Dis Model Mech       Date:  2008-10-28       Impact factor: 5.758

10.  Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.

Authors:  Judith Gault; Issam A Awad; Peter Recksiek; Robert Shenkar; Robert Breeze; Michael Handler; Bette K Kleinschmidt-DeMasters
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.